Manjunath Gangadharan Sells 1,802 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CAO Manjunath Gangadharan sold 1,802 shares of the firm’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total value of $247,198.36. Following the completion of the transaction, the chief accounting officer owned 5,083 shares in the company, valued at $697,285.94. The trade was a 26.17% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 4.2%

Shares of Adtalem Global Education stock traded down $5.97 during trading hours on Friday, reaching $134.71. 388,853 shares of the company’s stock were exchanged, compared to its average volume of 368,459. Adtalem Global Education Inc. has a 1 year low of $86.97 and a 1 year high of $156.26. The stock has a market capitalization of $4.59 billion, a P/E ratio of 19.13, a P/E/G ratio of 1.02 and a beta of 0.62. The firm has a fifty day moving average price of $127.08. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. The business had revenue of $501.38 million during the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, research analysts predict that Adtalem Global Education Inc. will post 9 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CVSA. Barrington Research reissued an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research note on Monday, June 8th. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Truist Financial increased their price target on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Wednesday, August 19th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Adtalem Global Education currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. Hedge funds and other institutional investors own 98.84% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.